Stock ABTI ALTEROLA BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Alterola Biotech, Inc.

Equities

ABTI

US02152V1035

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 07:00:00 10/05/2024 pm IST 		5-day change 1st Jan Change
0.0033 USD -10.81% Intraday chart for Alterola Biotech, Inc. -10.81% -8.33%
20/02 Alterola Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
2023 Alterola Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI

Valuation

Fiscal Period: March 2022 2023
Capitalization 1 173.1 35.27
Enterprise Value (EV) 1 173.3 36.67
P/E ratio -26.2 x -20.2 x
Yield - -
Capitalization / Revenue - -
EV / Revenue - -
EV / EBITDA - -
EV / FCF 9,07,89,391 x -5,78,09,905 x
FCF Yield 0% -0%
Price to Book 16.2 x 3.49 x
Nbr of stocks (in thousands) 7,86,633 8,07,048
Reference price 2 0.2200 0.0437
Announcement Date 10/06/22 10/07/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2021 2022 2023
Net sales - - -
EBITDA - - -
EBIT 1 -0.3416 -6.471 -1.697
Operating Margin - - -
Earnings before Tax (EBT) 1 -0.343 -6.471 -1.897
Net income 1 -0.343 -6.471 -1.742
Net margin - - -
EPS - -0.008404 -0.002160
Free Cash Flow - 1.908 -0.6344
FCF margin - - -
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 19/10/21 10/06/22 10/07/23
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2021 2022 2023
Net Debt 1 0.03 0.2 1.41
Net Cash position 1 - - -
Leverage (Debt/EBITDA) - - -
Free Cash Flow - 1.91 -0.63
ROE (net income / shareholders' equity) - -127% -16.6%
ROA (Net income/ Total Assets) - -66.7% -8.66%
Assets 1 - 9.703 20.13
Book Value Per Share - 0.0100 0.0100
Cash Flow per Share - 0 0
Capex - - -
Capex / Sales - - -
Announcement Date 19/10/21 10/06/22 10/07/23
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Bio Therapeutic Drugs

1st Jan change Capi.
ALTEROLA BIOTECH, INC. Stock Alterola Biotech, Inc.
-8.33% 4.56M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+5.33% 111B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+12.11% 105B
BIONTECH SE Stock BioNTech SE
-12.56% 22.34B
ARGENX SE Stock argenx SE
-3.70% 21.93B
GENMAB A/S Stock Genmab A/S
-6.03% 18.59B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-35.21% 18.12B
BEIGENE, LTD. Stock BeiGene, Ltd.
-10.86% 16.96B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+5.10% 13.7B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+37.57% 12.45B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. ABTI Stock
  4. Financials Alterola Biotech, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW